← Back to Unjha Formulations Ltd Overview

📊Financials 📈PE Ratio 🥧Shareholding 💰Dividend 📋Quarterly ⚖️Balance Sheet 💹P&L 🌊Cash Flow

UNJHAFORPharmaceuticals

Unjha Formulations Ltd — Financial Ratios & Key Metrics

₹20.29

-1.10%

P/E Ratio10.74xIndustry: 31.77x

ROE13.97%Return on equity

ROCE18.06%Return on capital

Debt/Equity0.00Debt free ✓

💎

Valuation & Profitability

P/E Ratio

10.74x

Industry Average P/E

31.77x

Dividend Yield

0.00%

Market Cap

₹10.96 (Cr)

Sales Growth 5Y

5.53%

Profit Growth 5Y

5.75%

EPS Growth 5Y

5.75%

OPM 5Y Avg

2.84%

📉

Price Returns

1 Month

+1.87%

3 Months

-2.20%

6 Months

+6.26%

1 Year

-18.20%

52W Low

₹19

Current

₹20

52W High

₹30

11% of 52-week range — Near lows

🔬

Technical Indicators

Neutral

Momentum is balanced — neither overbought nor oversold.

SMA 50

₹22

▼ Price below SMA 50 — Bearish

SMA 200

₹24

▼ Long-term downtrend

Volume Signal

228% of avg

Above average volume — strong conviction behind price move

Technical indicators are for educational purposes only. Not investment advice.

More on Unjha Formulations Ltd

Overview Financials PE History Shareholding Quarterly Balance Sheet P&L Cash Flow Pharmaceuticals Stocks Screener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.